Nuveen
TYRA icon

Nuveen’s Tyra Biosciences TYRA Stock Holding History

Nuveen’s Portfolio TYRA Stock Details TYRA Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2026
Q2 		$2.52M Buy
78,829
+27,989
+55% +$926K ﹤0.01% 2464
2026
Q1 		$1.95M Buy
50,840
+3,491
+7% +$113K ﹤0.01% 2289
2025
Q4 		$1.24M Sell
47,349
-33,092
-41% -$608K ﹤0.01% 2507
2025
Q3 		$1.13M Hold
80,441
– – ﹤0.01% 2562
2025
Q2 		$770K Buy
80,441
+30,443
+61% +$289K ﹤0.01% 2715
2025
Q1 		$465K Hold
49,998
– – ﹤0.01% 2924
2024
Q4 		$695K Hold
49,998
– – ﹤0.01% 2859
2024
Q3 		$1.18M Sell
49,998
-42,660
-46% -$896K ﹤0.01% 2686
2024
Q2 		$1.48M Buy
92,658
+66,945
+260% +$1.15M ﹤0.01% 2528
2024
Q1 		$422K Hold
25,713
– – ﹤0.01% 3023
2023
Q4 		$356K Buy
25,713
+6,957
+37% +$90.1K ﹤0.01% 3106
2023
Q3 		$258K Hold
18,756
– – ﹤0.01% 2990
2023
Q2 		$319K Hold
18,756
– – ﹤0.01% 3008
2023
Q1 		$301K Hold
18,756
– – ﹤0.01% 2918
2022
Q4 		$143K Hold
18,756
– – ﹤0.01% 3079
2022
Q3 		$165K Hold
18,756
– – ﹤0.01% 3127
2022
Q2 		$134K Buy
18,756
+356
+2% +$2.83K ﹤0.01% 3179
2022
Q1 		$197K Hold
18,400
– – ﹤0.01% 3196
2021
Q4 		$259K Buy
+18,400
New +$366K ﹤0.01% 3199

Other funds holding TYRA

RCM
RA Capital Management Boston, Massachusetts $11.5B AUM 168.77% 1-Year Est. Return
Fidelity Investments
Fidelity Investments Boston, Massachusetts $2.3T AUM 54.33% 1-Year Est. Return
JT
Jupiter Topco New York $245B AUM
APMC
Alta Partners Management Company Jackson, Wyoming $127M AUM 230.85% 1-Year Est. Return
NI
Nextech Invest Zurich, Switzerland $2.11B AUM 413.84% 1-Year Est. Return
TCM
TCG Crossover Management Palo Alto, California $4.16B AUM 983.43% 1-Year Est. Return
BlackRock
BlackRock New York $6.73T AUM 46.02% 1-Year Est. Return
T. Rowe Price Associates
T. Rowe Price Associates Baltimore, Maryland $999B AUM 46.22% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $3.37T AUM 44.26% 1-Year Est. Return
CC
Commodore Capital New York $1.68B AUM 375.52% 1-Year Est. Return

Nuveen's TYRA Position: Q2 2026 in Review

Nuveen increased its Tyra Biosciences (TYRA) stake by 55% in Q2 2026, buying an estimated $926K and bringing the position to 78,829 shares worth $2.52M. The position accounts for ﹤0.01% of the portfolio, ranked #2464.

Nuveen first reported a position in TYRA in Q4 2021 and has held it in 19 quarters since. 168 funds tracked by Wall St. Rank hold TYRA as of Q2 2026.

  • Nuveen held 78,829 shares of Tyra Biosciences worth $2.52M as of Q2 2026.
  • Nuveen bought 27,989 Tyra Biosciences shares in Q2 2026, an estimated $926K.
  • Tyra Biosciences made up ﹤0.01% of Nuveen's portfolio in Q2 2026, its #2464 holding.
  • Nuveen first reported a position in Tyra Biosciences in Q4 2021 and has held it in 19 quarters since.
  • 168 funds tracked by Wall St. Rank held Tyra Biosciences as of Q2 2026.

Based on Nuveen's 13F filing for Q2 2026, filed 11 Aug 2026.